Capstone Investment Advisors
MRK icon

Capstone Investment Advisors’s Merck MRK Stock Holding History

Capstone Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.8M Buy
397,200
+35,700
+10% +$4.12M 0.08% 94
2025
Q4 		$38.1M Sell
361,500
-73,200
-17% -$6.87M 0.07% 116
2025
Q3 		$36.5M Buy
434,700
+195,800
+82% +$16.1M 0.07% 129
2025
Q2 		$18.9M Sell
238,900
-28,200
-11% -$2.24M 0.05% 147
2025
Q1 		$24M Sell
267,100
-170,200
-39% -$15.9M 0.06% 149
2024
Q4 		$43.5M Buy
437,300
+29,800
+7% +$3.07M 0.11% 109
2024
Q3 		$46.3M Sell
407,500
-56,700
-12% -$6.74M 0.14% 93
2024
Q2 		$57.5M Buy
464,200
+28,900
+7% +$3.72M 0.18% 73
2024
Q1 		$57.4M Sell
435,300
-36,200
-8% -$4.46M 0.21% 70
2023
Q4 		$51.4M Buy
471,500
+198,400
+73% +$20.6M 0.15% 98
2023
Q3 		$28.1M Buy
273,100
+137,600
+102% +$14.8M 0.13% 111
2023
Q2 		$15.6M Buy
135,500
+27,400
+25% +$3.11M 0.08% 174
2023
Q1 		$11.5M Sell
108,100
-26,600
-20% -$2.87M 0.06% 218
2022
Q4 		$14.9M Buy
134,700
+34,100
+34% +$3.49M 0.11% 161
2022
Q3 		$8.66M Sell
100,600
-241,600
-71% -$21.6M 0.05% 259
2022
Q2 		$31.2M Sell
342,200
-460,200
-57% -$40.8M 0.15% 82
2022
Q1 		$65.8M Sell
802,400
-1,437,500
-64% -$113M 0.18% 70
2021
Q4 		$172M Buy
2,239,900
+80,100
+4% +$6.38M 0.29% 67
2021
Q3 		$162M Buy
2,159,800
+402,400
+23% +$30.6M 0.32% 58
2021
Q2 		$137M Buy
1,757,400
+353,080
+25% +$26.3M 0.31% 69
2021
Q1 		$103M Buy
1,404,320
+707,400
+102% +$52.2M 0.3% 72
2020
Q4 		$54.4M Buy
696,920
+22,742
+3% +$1.74M 0.18% 97
2020
Q3 		$53.4M Buy
674,178
+215,154
+47% +$16.9M 0.27% 67
2020
Q2 		$33.9M Buy
459,024
+100,713
+28% +$7.58M 0.22% 79
2020
Q1 		$26.3M Sell
358,311
-964,684
-73% -$75.8M 0.42% 29
2019
Q4 		$115M Buy
1,322,995
+234,961
+22% +$19.3M 0.62% 23
2019
Q3 		$87.4M Buy
1,088,034
+245,547
+29% +$19.7M 0.6% 30
2019
Q2 		$67.4M Buy
842,487
+224,272
+36% +$17.2M 0.49% 35
2019
Q1 		$49.1M Buy
618,215
+283,798
+85% +$21.2M 0.45% 45
2018
Q4 		$24.4M Buy
334,417
+162,650
+95% +$11.5M 0.3% 54
2018
Q3 		$11.6M Buy
171,767
+94,320
+122% +$6.01M 0.13% 120
2018
Q2 		$4.49M Buy
+77,447
New +$4.37M 0.07% 167
2017
Q2 		– Sell
-39,195
Closed -$2.37M – 828
2017
Q1 		$2.37M Sell
39,195
-1,048
-3% -$63.6K 0.06% 252
2016
Q4 		$2.26M Buy
40,243
+29,029
+259% +$1.7M 0.07% 258
2016
Q3 		$667K Buy
+11,214
New +$656K 0.01% 461
2015
Q1 		– Sell
-24,523
Closed -$1.33M – 319
2014
Q4 		$1.33M Hold
24,523
– – 0.02% 243
2014
Q3 		$1.39M Sell
24,523
-22,218
-48% -$1.25M 0.02% 313
2014
Q2 		$2.58M Buy
46,741
+4,402
+10% +$240K 0.03% 244
2014
Q1 		$2.29M Sell
42,339
-29,763
-41% -$1.54M 0.03% 242
2013
Q4 		$3.44M Sell
72,102
-191,680
-73% -$8.76M 0.04% 254
2013
Q3 		$12M Buy
263,782
+212,535
+415% +$9.7M 0.12% 97
2013
Q2 		$2.27M Buy
+51,247
New +$2.29M 0.02% 234

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capstone Investment Advisors's MRK Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Merck (MRK) stake by 80% in Q1 2026, selling an estimated $2.94M and leaving 6,472 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Capstone Investment Advisors first reported a position in MRK in Q3 2013 and has held it in 35 quarters since. The position peaked at $13.3M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capstone Investment Advisors held 6,472 shares of Merck worth $779K as of Q1 2026.
  • Capstone Investment Advisors sold 25,432 Merck shares in Q1 2026, an estimated $2.94M.
  • Merck made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #953 holding.
  • Capstone Investment Advisors first reported a position in Merck in Q3 2013 and has held it in 35 quarters since.
  • Capstone Investment Advisors's Merck position peaked at $13.3M in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.